Purple biotech reports second half and full-year 2021 financial results

Rehovot, israel, feb. 09, 2022 (globe newswire) -- purple biotech ltd. ("purple biotech", or the "company") (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced financial results for the year and the six months ended december 31, 2021.

PPBT Ratings Summary

PPBT Quant Ranking